Physician

Eliot Robert Dow, M.D., PH.D.

According to 2025 Medicare claims, Eliot Dow, M.D., PH.D. (NPI: 1740711647) practices ophthalmology in the Vallejo, CA market, with the plurality of this provider's patient population coming from Solano, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC. (NPI: 1497897532; TIN: 942442567) and primary practice location at 94534-1072. Dow is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), NeueHealth Premier ACO, LLC (ACO ID: D0181), and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under both the MSSP and REACH models.

Dow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,323 traditional Medicare patients, billed 37,425 HCPCS/CPT codes, and received $2,555,645 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 435 prescription claims across 199 beneficiaries totaling $19,902 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 20 records totaling $2,387. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,602 to $19,902. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2022 Medicare payment: $2,345 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $478,050 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,555,645 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20221938$2,345
20234686,581$478,050
20241,32337,425$2,555,645

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10.0K$20K2017 Drug cost: $2,602 (USD; Tot_Drug_Cst)2018 Drug cost: $716 (USD; Tot_Drug_Cst)2019 Drug cost: $7,679 (USD; Tot_Drug_Cst)2020 Drug cost: $17,898 (USD; Tot_Drug_Cst)2021 Drug cost: $6,786 (USD; Tot_Drug_Cst)2022 Drug cost: $5,831 (USD; Tot_Drug_Cst)2023 Drug cost: $15,106 (USD; Tot_Drug_Cst)2024 Drug cost: $19,902 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171432$2,602
20181422$716
20191764$7,679
202047183$17,898
20212896$6,786
20222470$5,831
202384177$15,106
2024199435$19,902

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye417422$141
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more221221$130
67028Injection of drug into eye5361,312$104
92012Established patient problem focused exam of visual system478552$73
92134Imaging of retina1,2372,288$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1325,324$6,617
Brimonidine TartrateBrimonidine Tartrate251,725$1,411
Ketorolac TromethamineKetorolac Tromethamine471,727$1,235
OfloxacinOfloxacin661,533$831
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat494,120$778

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$2,387Ocular Therapeutix, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eliot Robert Dow, M.D., PH.D.?

Tedicare shows public-source Medicare data for Eliot Robert Dow, M.D., PH.D. (NPI 1740711647), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eliot Robert Dow, M.D., PH.D. have ACO affiliation data?

Eliot Robert Dow, M.D., PH.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419), NeueHealth Premier ACO, LLC (REACH, ACO ID D0181), and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to Eliot Robert Dow, M.D., PH.D.?

Eliot Robert Dow, M.D., PH.D. is linked to VITREO-RETINAL MEDICAL GROUP, INC. (billing NPI 1497897532) in the available physician profile data.

Does Eliot Robert Dow, M.D., PH.D. have Open Payments data?

Eliot Robert Dow, M.D., PH.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.